VR8
0.059
55.3%
KYN
0.03
-21.1%
BEO
0.12
50%
G11
0.2
-20%
IMM
0.056
27.3%
MQR
0.004
-20%
CMO
0.005
25%
ALB
0.049
-18.3%
EXT
0.005
25%
AM5
0.005
-16.7%
FZR
0.4
23.1%
CTQ
0.015
-16.7%
CRB
0.012
20%
MGU
0.005
-16.7%
LIO
0.012
20%
W2V
0.042
-16%
PKO
0.012
20%
PAR
0.24
-15.8%
1MC
0.033
17.9%
RVT
0.11
-15.4%
TZL
0.033
17.9%
SVG
0.006
-14.3%
EM2
0.007
16.7%
LEX
0.125
-13.8%
FEL
0.007
16.7%
RML
0.052
-13.3%
CTD
2.46
15.5%
CAZ
0.02
-13%
A8G
0.2
14.3%
FCT
0.007
-12.5%
CXU
0.12
14.3%
GT1
0.014
-12.5%
M96
0.008
14.3%
LIT
0.007
-12.5%
PCL
0.008
14.3%
OEL
0.007
-12.5%
YUG
0.049
14%
PLC
0.007
-12.5%
BPM
0.25
13.6%
ZEU
0.007
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Partners with US based

BlinkLab (ASX:BB1) has initiated a clinical study in partnership with US based Turning Pointe Autism Foundation.

The data obtained during the course of this collaboration will be used to finalise the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.

BlinkLab is an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism.

Read the ASX announcement: https://yourir.info/resources/3449d9aa01a61c6b/announcements/bb1.asx/6A1205872/BB1_BlinkLab_Partnership_with_Turning_Pointe_Autism_Foundation.pdf #BB1